Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Low valuations, looming deals: Why BB Biotech sees new cycle

In the latest 'Meet the Manager' video from Citywire, Dr Christian Koch explores how innovation, valuation and the firepower of big pharma could fuel a biotech recovery.
08.07.2025 - Christian Koch
Low valuations, looming deals: Why BB Biotech sees new cycle

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993